Canadian Cancer Trials Group Bulletins


Recent Publications

There were two recent publications -- the primary publication for Canadian Cancer Trials Group IND.179 and one related to Canadian Cancer Trials Group OV.21.

Canadian Cancer Trials Group IND.179 -- A Phase I Study of CCI-779 in Combination with Carboplatin and Paclitaxel in Patients with Advanced Solid Tumours

Kollmannsberger C, Hirte H, Siu LL, Mazurka J, Chi K, Elit L, Walsh W, Sederias J, Doyle A, Eisenhauer EA, Oza AM. Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179) (ONLINE). Ann Oncol 2011.

Canadian Cancer Trials Group OV.21 -- Phase II/III Trial of Intraperitoneal (IP) Plus Intravenous (IV) Chemotherapy Versus IV Carboplatin Plus Paclitaxel in Patients With Epithelial Ovarian Cancer Optimally Debulked at Surgery Following Neoadjuvant Intravenous Chemotherapy

Mackay HJ, Provencher D, Heywood M, Tu D, Eisenhauer EA, Oza AM, Meyer R. Phase II/III study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: Canadian Cancer Trials Group OV.21. Current Oncology 18: 84-90, 2011.